Regulation by the Brazilian National Health Surveillance Agency facilitating the international purchase of essential drugs for the fight against COVID-19 will continue to apply.
Browsing: anvisa
The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
Following a recommendation of Anvisa, the entry of foreigners is banned by land or water. The measure is temporary, and no lenght was detailed.
